Cannabis for Hepatitis

Hepatitis is inflammation of the liver and can be characterized as acute or chronic. Acute hepatitis usually lasts no more than a couple of months. Chronic hepatitis can be a lifelong debilitating disease.

Most commonly, the liver becomes inflamed as a result of the hepatic viruses A, B, C, D, or E, which are a major health problem worldwide. Viral hepatitis is contagious, while non-viral forms of hepatitis are not.

In some cases, toxins, alcohol, and many pharmacological medications such as acetaminophen and ibuprofen can also produce hepatitis.

Ratings for Cannabis and Hepatitis

Rated 1.0 / 5 (How Ratings Work)

Possibility of efficacy for cannabis in treatment of hepatitis.
Based on 9 Studies from 2003 - 2014

Studies on Cannabis and Hepatitis

Study Name, Description & Year

Rating

Endocannabinoid System Activation Contributes To Glucose Metabolism Disorders Of Hepatocytes And Promotes Hepatitis C Virus Replication
Laboratory Study — 2014

-1

Marijuana Smoking Does Not Accelerate Progression Of Liver Disease In HIV-hepatitis C Coinfection: A Longitudinal Cohort Analysis
Data were analyzed for 690 HCV polymerase chain reaction positive (PCR-positive) individuals without significant fibrosis or end-stage liver disease (ESLD) at baseline. — 2013

3

Attenuation Of Experimental Autoimmune Hepatitis By Exogenous And Endogenous Cannabinoids: Involvement Of Regulatory T Cells
Animal study (murine) — 2008

2

Evaluation Of Oral Cannabinoid-containing Medications For The Management Of Interferon And Ribavirin-induced Anorexia, Nausea And Weight Loss In Patients Treated For Chronic Hepatitis C Virus
21 patients with hepatitis C undergoing interferon and ribavirin therapy — 2008

3

Influence Of Cannabis Use On Severity Of Hepatitis C Disease
Baseline data from a prospective cohort study of 204 persons with chronic HCV infection were used for analysis. — 2008